Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061

N-acetyl-beta-D-glucosamine; 2-acetamido-2-deoxy-beta-D-glucose; 2-acetamido-2-deoxy-D-glucose; 2-acetamido-2-deoxy-glucose; N-ACETYL-D-GLUCOSAMINE

Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail.

heavy chain of human monoclonal antibody AZD8895

light chain of human monoclonal antibody Fab AZD8895

heavy chain of human monoclonal antibody Fab AZD1061

light chain of human monoclonal antibody Fab AZD1061

receptor binding domain (UNP residues 330-529)

S glycoprotein,E2,Peplomer protein,Spike glycoprotein

Severe acute respiratory syndrome coronavirus 2

5% PEG1000, 40% reagent alcohol, 0.1 M sodium phosphate dibasic/citric acid, pH 4.2

SARS-CoV-2, spike protein, receptor binding domain, human monoclonal antibody, VIRAL PROTEIN-IMMUNE SYSTEM complex